# Taxo.ai

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/taxo-ai

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.taxo.ai/
- Total disclosed funding: $5M
- Latest round: Seed (Mar 27, 2025)
- Investors on record: 3

## About

Taxo.ai, Inc. is a technology firm focused on automating healthcare administration through advanced artificial intelligence solutions tailored to enhance operational efficiency and patient care outcomes.Taxo.ai, Inc. specializes in AI-driven solutions for healthcare administration. Founded in 2024 in San Francisco, US, the company has completed 1 deal as of March 27, 2025, raising a total of USD 5.00 mn in Seed funding from Character, General Catalyst Partners, and Y Combinator. The founder's previous ventures are not publicly available.Taxo.ai, Inc. specializes in automating healthcare administration through its flagship product, Apex™, a proprietary language model tailored specifically for the healthcare sector. Apex™ employs advanced techniques such as ensemble modeling and consensus decision-making to deliver rapid and precise data extraction and reasoning tailored for healthcare administration tasks. The core use cases addressed by the product include streamlining administrative processes, enhancing decision-making capabilities, and facilitating improved patient care outcomes. Apex™ serves a diverse clientele that spans healthcare providers, insurance companies, and administrative organizations across various geographical markets, including the United States, Canada, and select countries in Europe. By focusing on these end users, Taxo aims to alleviate the administrative burden on healthcare professionals, allowing them to dedicate more time to patient care.Taxo.ai, Inc. generates revenue primarily through subscription-based models and partnerships established with healthcare organizations. Clients engage in agreements that provide access to the Apex™ platform, which may include tiered pricing structures based on the scale of usage and specific service levels. For instance, healthcare institutions might subscribe to different plans that allow them to utilize varying capacities of the Apex™ model, depending on their administrative needs. This structure not only fosters a continuous revenue stream but also strengthens the partnership between Taxo and its clients, ensuring ongoing support and updates. The transaction framework typically involves direct business-to-business (B2B) interactions, whereby healthcare administrations incorporate Taxo's services into their operational workflow to enhance efficiency and compliance.In March 2025, Taxo.ai, Inc. raised USD 5.00 mn in Seed funding co-led by Character, General Catalyst Partners, and Y Combinator. The company will use the funding to expand artificial intelligence platform development and increase hiring for key roles. Future initiatives include the launch of new products designed to enhance healthcare operational efficiency, with specific release dates to be determined, and targeted expansion into new markets in Europe and Asia by 2026.

## Funding rounds

- Seed, Mar 27, 2025, $5M — General Catalyst Partners, Y Combinator, Character

## Investors

- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Seed
- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed
- Character (https://capitalatlas.ai/funds/character) — Seed